Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Mathias Schemmerer und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Consultant Laboratory for HAV and HEV, Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, Regensburg, Ger…. Hauptthemen laut MEDLINE: Hepatitis E virus, Hepatitis E, Viral Load, RNA, Viral. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Boehringer Ingelheim, Siemens Healthcare GmbH.
Abstract (Originalsprache)
Recently, hepatitis E virus (HEV, Paslahepevirus balayani ) particles were detected for the first time in the ejaculate of two chronically infected patients. Since then, we have been able to detect HEV in ejaculate in five further patients, and thus in a total of seven out of nine (78%) chronically infected men (age 36–67 years, median 56 years). In five patients, the HEV RNA concentration was more than 100‐fold higher compared to the serum, while in two patients, the viral load was more than 10‐fold lower. However, it has remained unclear whether viral particles shed in the ejaculate were infectious, as a previous cell culture model had failed to demonstrate the infectivity. In the current study, we employed an optimized HEV cell culture system based on overconfluent PLC/PRF/5 cells to investigate the infectivity of HEV particles from ejaculate and other body fluids. With this approach, we were able to show for the first time that HEV particles in the ejaculate from several patients were infectious. HEV replicated to high viral loads of 1e9 HEV RNA copies per ml. This indicates that HEV‐positive ejaculate could bear a risk of infection for sexual partners.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Consultant Laboratory for HAV and HEV, Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, Regensburg, Germany.
- Gastroenterology, University Hospital Düsseldorf, Düsseldorf, Germany.
- Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany.
- Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Microbiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
- Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
ORCID-Profile: Mathias Schemmerer
Förderung
- Bundesministerium für Bildung und Forschung
- Boehringer Ingelheim
- Siemens Healthcare GmbH
Zitieren
APA
Schemmerer, M., Bock, H. H., Schattenberg, J. M., Huber, S., Polywka, S., Mader, M., Lohse, A. W., Todt, D., Steinmann, E., Wenzel, J. J., Horvatits, T., & Pischke, S. (2024). Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients. Journal of Medical Virology. https://doi.org/10.1002/jmv.29735
Vancouver
Schemmerer M, Bock HH, Schattenberg JM, Huber S, Polywka S, Mader M, et al. Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients. Journal of Medical Virology. 2024. doi:10.1002/jmv.29735
BibTeX
@article{Schemmerer2024,
author = {Schemmerer, Mathias and Bock, Hans H and Schattenberg, Jörn M and Huber, Samuel and Polywka, Susanne and Mader, Maria and Lohse, Ansgar W and Todt, Daniel and Steinmann, Eike and Wenzel, Jürgen J and Horvatits, Thomas and Pischke, Sven},
title = {Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29735}
}
EUVIMED